ArticleNeoplasia (New York, N.Y.)2012

Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.

Katiuscia Bonezzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.